We’re excited to kick off the AI FOMO Road Show at JP Morgan Conference in SF! CC: Kshitij Jaggi Ben Freeberg
关于我们
- 网站
-
https://risalabs.ai
RISA Labs Inc的外部链接
- 所属行业
- 研究服务
- 规模
- 11-50 人
- 总部
- Palo Alto,California
- 类型
- 私人持股
- 创立
- 2024
- 领域
- Prior Authorization、Oncology、Clinical Operations、Clinical AI、AI Research和Multi agent system
地点
RISA Labs Inc员工
动态
-
Happy new year! from all of us at RISA Labs Inc. Sharing extract from note shared earlier internally. Lot to look forward in 2025!
-
-
What a remarkable way to close out #2024! Looking back, the past 12 months at #RISA have been nothing short of a roller coaster ride. As they say, the dots always connect in hindsight, and that’s exactly what 2024 has been like. We’ve had our fair share of ups and downs: ?? “Healthcare is a tough market to crack.” ?? “This is a competitive space you’re in.” ?? “Selling to large enterprises? Don’t even bother, they take 12 months to make a decision.” Yet, here we are, consistently closing customers in less than 90 days. Not to mention, it’s because of our early partners, whose unwavering passion for addressing inefficiencies in U.S. healthcare and steadfast commitment to advancing the industry truly stand out: imagine being in a meeting on Dec 31st, discussing how RISA's AI can genuinely transform existing workflows. As we begin #2025 on a high note, the excitement couldn’t be greater as we continue to innovate in mission-critical rooms with our "Agentverse." Honestly, it may sound highly ambitious when Kshitij talks about it, but that’s exactly what RISA embodies: pushing boundaries and driving meaningful innovation. There’s so much to build, big challenges to tackle, and incredible journeys to unfold as we learn and grow every day. But it’s the team, steadfast in their patience and perseverance and always staying closest to their customers, that I would bet on every single time. That’s where our true strength lies. Kudos to Team #RISA, truly excited for what’s coming up in 2025! If you’re mission-driven and bring a unique skill set to the table, we are looking for you. Keep an eye on our LinkedIn page for job postings. Here’s to a phenomenal 2025 for us all! RISA Labs Inc
-
I am hiring genius software engineers and AI researchers ICs, DM Himanshu Pandey, Akhil Amod, Aditi Deepanvita, or me ASAP. I am Shivang, the CTO of Risa Labs Inc., which is based in Palo Alto, CA, and Cambridge, MA. We are building service-as-a-software (not software-as-a-service) for yearly n-billion intelligent-service transactions. Risa Labs is building state-of-the-art service-as-a-software infrastructure for critical and heavily regulated enterprises, such as health systems, insurance, pharma, life sciences, federal governance, federal execution, or any big-4 led service layer that involves complex coordination. Risa Lab's mission, at its core, is to build an intelligent simulation company that emulates and replaces service-led workflow with intelligent technologies in 10x (or more) efficiency gain and 0.1x (or less) pricing. One of the primary focuses of Risa Labs is the oncology back office, specifically prior authorization, which involves complex coordination between healthcare providers, healthcare payers, and pharmaceutical companies. We are hiring for multiple IC levels, at Risa we call it Level 100, Level 150, Level 200, and Level 300, each next level signifies a more sophisticated understanding and hands-on experience of tech stack. For level 100: I am looking for a genius developer with a deep understanding of one or many tech competencies in software development, AI DevOps, software architecture, frontend, or any other tech-dev vertical of your choice where you can prove your genuine-deep understanding and past work to proof that. CTC would be up to 43LPA* for the Bangalore office. For level 200: I am looking for a genius developer with everything of level 100 plus proven ownership with the result of overall one or multiple sub-projects, which could prove caveats of the past problems and your novel contribution to the problem in hand, the projects could be implementing tailored Kubernetes pipeline for tech stack resulting in cost optimization, or similar projects. CTC would be up to 55LPA* for the Banglore office. For level 300: I am looking for a genius developer with level 200 plus proven ownership of tech-stack architecture level depth, who should have worked closely with product managers and customers to engineer solutions. Solutions like multi-agent systems for medical-necessity or similar. CTC would be up to 75LPA* for the Banglore office. FAQs 1. We do level evaluation bi-yearly and encourage everyone to qualify for the next level 2. We do have levels beyond level 300, those are more toward leadership roles 3. Anyone could qualify for leadership roles, based on requirements of level 400 and beyond 4. We do have fractional levels as well, these are based on the candidate's assessment * CTC includes fixed, bonus component, and equity
-
Wrap of Day 1 of placements at IITK & IITD for RISA Labs Inc. Our first drive to onboard RISians fresh out of college. Good luck to other students sitting for placements this year! Credits to Aditi Deepanvita and Himanshu Pandey for leading it successfully.
-
-
Proud to celebrate the journey of RISA Labs Inc ?? Earlier this week, RISA Labs shared its story at Stanford University Graduate School of Business, showcasing how it’s building the critical infrastructure to redefine oncology care for 2030. Collaborating with Stanford alumni as advisors, investors, and partners, RISA Labs continues to bridge cutting-edge technology with transformative healthcare solutions. We at z21 Ventures are thrilled to support Kshitij Jaggi and team in its mission. Abhinav Shashank Raj Shekhar Singh Jyotika Gupta Sudarshan Ravi Jha Shachi Shah Shivam Bhotika Ritik Singh Anand Akela
It was great sharing RISA Labs Inc’s story at Stanford University Graduate School of Business earlier this week. I have been privileged to work with Stanford alumni as advisors, investors, partners in RISA’s journey, as we build the missing infrastructure for the future of medicine in oncology (FOMO) 2030! We delved into: Why top cancer centers and healthcare organisations work with us? How we’re leveraging AI to transform a legacy industry and guiding them to the new world order? Why we exist? And most importantly, why now? Look forward to working closely with more of you! Thanks again to Henry Lu for inviting me, Karn Nahata and Joseph Wise for introducing us! PC. Abheet Jain
-
-
We’ve limited seats in our AI research group, and will be at top 3 IITs for placement drive in India and are spending time with graduating students here at Stanford in Bay Area. It’s exciting early days for us, with solid foundation to build and grow fast on! We’re hunting across 2 major groups: 1. AI Enablers (Sales, go-to-market, workflow transformation, crossover capital strategy, corp dev, biz dev). On-site US team, working on day-to-day basis with me across Bay Area, New York and Boston. 2. AI Engineers (on research and applied AI problem statements). Spread across Bay Area and Bangalore. JDs across both groups will vary depending on campus. Good luck to all those making important career decision in next few days. Look forward to interacting & hopefully working with the best of you in 2025 and beyond as you scale RISA with us More on what it means to be a RISian in coming posts. I can always be reached at [email protected] About RISA: “Oncology First. https://risalabs.ai is a mission driven AI research group and deployment company building proprietary Digital Twin architecture powered by AI-driven Multi-Agent Systems to solve hardest problems that matter to the society. In the AI age, we exist for humanity to win.”
-
It was great sharing RISA Labs Inc’s story at Stanford University Graduate School of Business earlier this week. I have been privileged to work with Stanford alumni as advisors, investors, partners in RISA’s journey, as we build the missing infrastructure for the future of medicine in oncology (FOMO) 2030! We delved into: Why top cancer centers and healthcare organisations work with us? How we’re leveraging AI to transform a legacy industry and guiding them to the new world order? Why we exist? And most importantly, why now? Look forward to working closely with more of you! Thanks again to Henry Lu for inviting me, Karn Nahata and Joseph Wise for introducing us! PC. Abheet Jain
-
-
Oncology?as the starting point, to lay down Blueprint for other diseases. Super grateful to partner with Ben Freeberg of Oncology Ventures today as we bring the best of RISA to point of care in OV's family and beyond. With focus on prior authorisations, we're building the foundational Clinical AI multi-agent system for healthcare and life sciences. As Ben astutely says, "RISA is primed to transform oncology PA—and, by extension, healthcare as a whole." cc: Binny Bansal Raj Shekhar Singh Ashish Gupta Neeraj Arora "Dr.V"
Oncology Ventures is excited to announce its investment into RISA. Kshitij Jaggi and the RISA team have built an AI platform that is transforming Prior Authorization, focused on the most complicated and high-touch disease area, oncology. If you and your team would like to learn more about how you can implement RISA into your workflow, please reach out to us. Detail on our investment thesis here: